| Epidemiology of acute renal failure: a prospective, multicenter, community-based study F Liano, J Pascual, Madrid Acute Renal Failure Study Group Kidney international 50 (3), 811-818, 1996 | 1444 | 1996 |
| Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells M Yáñez-Mó, E Lara-Pezzi, R Selgas, M Ramírez-Huesca, ... New England Journal of Medicine 348 (5), 403-413, 2003 | 950 | 2003 |
| The spectrum of acute renal failure in the intensive care unit compared with that seen in other settings F Liano, E Junco, R Madero, J Pascual, E Verde Kidney International-Supplements 66, S16-S24, 1998 | 762 | 1998 |
| Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions LS Aroeira, A Aguilera, JA Sánchez-Tomero, MA Bajo, G del Peso, ... Journal of the American Society of Nephrology 18 (7), 2004-2013, 2007 | 454 | 2007 |
| Functional longevity of the human peritoneum: how long is continuous peritoneal dialysis possible? Results of a prospective medium long-term study R Selgas, MJ Fernadez-Reyes, E Bosque, MA Bajo, F Borrego, ... American Journal of Kidney Diseases 23 (1), 64-73, 1994 | 301 | 1994 |
| Risk factors for abdominal wall complications in peritoneal dialysis patients G Del Peso, MA Bajo, O Costero, C Hevia, F Gil, C Díaz, A Aguilera, ... Peritoneal dialysis international 23 (3), 249-254, 2003 | 278 | 2003 |
| Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor LS Aroeira, A Aguilera, R Selgas, M Ramírez-Huesca, ML Pérez-Lozano, ... American Journal of Kidney Diseases 46 (5), 938-948, 2005 | 259 | 2005 |
| Thyroid dysfunction and kidney disease: An update P Iglesias, MA Bajo, R Selgas, JJ Díez Reviews in Endocrine and Metabolic Disorders 18, 131-144, 2017 | 239 | 2017 |
| Serum concentrations of leptin, adiponectin and resistin, and their relationship with cardiovascular disease in patients with end‐stage renal disease JJ Díez, P Iglesias, MJ Fernández‐Reyes, A Aguilera, MA Bajo, ... Clinical endocrinology 62 (2), 242-249, 2005 | 216 | 2005 |
| Preventing peritoneal membrane fibrosis in peritoneal dialysis patients Q Zhou, MA Bajo, G Del Peso, X Yu, R Selgas Kidney international 90 (3), 515-524, 2016 | 192 | 2016 |
| Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. Part I. Classification, epidemiology, pathophysiology, genetics, clinical … T Caballero, ML Baeza, R Cabañas, A Campos, S Cimbollek, ... Journal of investigational allergology & clinical immunology 21 (5), 333-47 …, 2011 | 183 | 2011 |
| Anorexigen (TNF-alpha, cholecystokinin) and orexigen (neuropeptide Y) plasma levels in peritoneal dialysis (PD) patients: their relationship with nutritional parameters. A Aguilera, R Codoceo, R Selgas, P Garcia, M Picornell, C Diaz, ... Nephrology, Dialysis, Transplantation: Official Publication of the European …, 1998 | 175 | 1998 |
| Immunohistochemical characterization of fibroblast subpopulations in normal peritoneal tissue and in peritoneal dialysis-induced fibrosis JA Jiménez-Heffernan, A Aguilera, LS Aroeira, E Lara-Pezzi, MA Bajo, ... Virchows Archiv 444, 247-256, 2004 | 169 | 2004 |
| Epithelial-to-mesenchymal transition of mesothelial cells is an early event during peritoneal dialysis and is associated with high peritoneal transport G Del Peso, JA Jiménez-Heffernan, MA Bajo, LS Aroeira, A Aguilera, ... Kidney International 73, S26-S33, 2008 | 162 | 2008 |
| Epithelial-to-mesenchymal transition of the mesothelial cell—its role in the response of the peritoneum to dialysis R Selgas, A Bajo, JA Jiménez-Heffernan, JA Sánchez-Tomero, ... Nephrology Dialysis Transplantation 21 (suppl_2), ii2-ii7, 2006 | 157 | 2006 |
| Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. Part II. Treatment, follow-up, and special situations T Caballero, ML Baeza, R Cabañas, A Campos, S Cimbollek, ... J Investig Allergol Clin Immunol 21 (6), 422-441, 2011 | 152 | 2011 |
| Alternative activation of macrophages in human peritoneum: implications for peritoneal fibrosis T Bellón, V Martínez, B Lucendo, G del Peso, MJ Castro, LS Aroeira, ... Nephrology Dialysis Transplantation 26 (9), 2995-3005, 2011 | 144 | 2011 |
| Clinical experience with tamoxifen in peritoneal fibrosing syndromes. G del Peso, MA Bajo, F Gil, A Aguilera, S Ros, O Costero, MJ Castro, ... Advances in peritoneal dialysis. Conference on Peritoneal Dialysis 19, 32-35, 2003 | 129 | 2003 |
| Low-GDP peritoneal dialysis fluid (‘balance’) has less impact in vitro and ex vivo on epithelial-to-mesenchymal transition (EMT) of mesothelial cells than a … MA Bajo, ML Pérez-Lozano, P Albar-Vizcaino, G del Peso, MJ Castro, ... Nephrology Dialysis Transplantation 26 (1), 282-291, 2011 | 98 | 2011 |
| Ex vivo analysis of dialysis effluent-derived mesothelial cells as an approach to unveiling the mechanism of peritoneal membrane failure M López-Cabrera, A Aguilera, LS Aroeira, M Ramírez-Huesca, ... Peritoneal dialysis international 26 (1), 26-34, 2006 | 97 | 2006 |
